159 related articles for article (PubMed ID: 8828023)
1. Comparison of the efficacy of ebastine 10mg and 20mg once daily with that of cetirizine 10mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study.
Cohen B; Gehanno P
Drugs; 1996; 52 Suppl 1():26-9. PubMed ID: 8828023
[No Abstract] [Full Text] [Related]
2. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
3. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
Gehanno P; Bremard-Oury C; Zeisser P
Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
Storms WW
Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
[TBL] [Abstract][Full Text] [Related]
5. [Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
[No Abstract] [Full Text] [Related]
6. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ebastine with cetirizine.
Volkerts ER
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):465-6. PubMed ID: 9396983
[No Abstract] [Full Text] [Related]
8. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical studies with ebastine: efficacy and tolerability.
Luria X
Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
[TBL] [Abstract][Full Text] [Related]
10. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
12. Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity.
Purohit A; Duvernelle C; Melac M; Benabdesselam O; Pauli G; Frossard N
Eur J Clin Pharmacol; 1999 Oct; 55(8):589-92. PubMed ID: 10541777
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
14. [Effects of double-dose antihistamine or combined therapy in allergic rhinitis].
Li LS; Guan K; Cui L; Wang RQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):27-32. PubMed ID: 29798206
[No Abstract] [Full Text] [Related]
15. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
Frank H; Gillen M; Rohatagi SS; Lim J; George G;
J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
19. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Kalis B
Drugs; 1996; 52 Suppl 1():30-4. PubMed ID: 8828024
[TBL] [Abstract][Full Text] [Related]
20. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
